Invivyd, Inc. (Nasdaq: IVVD) specializes in developing potent, virus-resistant medicines using a proprietary integrated technology platform. The company focuses on creating best-in-class antibodies through advanced assessment and adaptation techniques. In March 2024, Invivyd received emergency use authorization for a monoclonal antibody, highlighting its innovation in treating immune-compromised patients.
Invivyd is seeking a Strategic Account Manager to drive antibody-based therapies and protect vulnerable populations affected by viral threats. This role involves collaborating with various stakeholders, leading territory business plans, and educating customers on the value of Invivyd’s technology. It's a sales and business-oriented position focused on delivering solutions and exceeding customer expectations.
Invivyd, Inc. (Nasdaq: IVVD) specializes in developing potent, virus-resistant medicines using a proprietary integrated technology platform. The company focuses on creating best-in-class antibodies through advanced assessment and adaptation techniques. In March 2024, Invivyd received emergency use authorization for a monoclonal antibody, highlighting its innovation in treating immune-compromised patients.